Start for free
Start for free
ShenZhen GTJA Investment Group logo

ShenZhen GTJA Investment Group

Asia, Guangdong, China, Shenzhen

Description

ShenZhen GTJA Investment Group was founded in 2001

Investor Profile

ShenZhen GTJA Investment Group has made 8 investments, with 2 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (38%)
  • Series D (25%)
  • Series C (25%)
  • Seed (13%)

Country Focus

  • China (88%)
  • United States (13%)

Industry Focus

  • Biotechnology
  • Medical
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Therapeutics
  • Hospital
  • Wellness
  • Oncology
  • Automotive
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ShenZhen GTJA Investment Group frequently co-invest with?

SNÖ Ventures
SNÖ Ventures
Europe, Oslo, Norway, Oslo
Co-Investments: 1
GN
Co-Investments: 1
BC
Co-Investments: 1
Cenova
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Galaxy Capital
Galaxy Capital
Asia, Jiangsu, China, Suzhou
Co-Investments: 1
CC
CFS Capital
North America, Washington, United States, Spokane
Co-Investments: 1
BB
Beida Biomedical Industry Fund
Asia, Kagoshima, Japan, China
Co-Investments: 1
Yanchuang Capital
Yanchuang Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
ZV
Co-Investments: 1
Oriza Holdings
Oriza Holdings
Asia, Jiangsu, China, Suzhou
Co-Investments: 1

What are some of recent deals done by ShenZhen GTJA Investment Group?

Qingpai Technology

Haidian, Beijing, China

Qingpai Technology is a developer of photoacoustic biomedical imaging technology.

BiopharmaHealth CareMedical
SeedFeb 6, 2025
Rosenbot

Beijing, Beijing, China

Rosenbot provides medical robot technology and uses technological innovation to promote the reform of medical models.

MedicalMedical DeviceRobotics
Series CJan 20, 2025
TenNor Therapeutics

Westfield, New Jersey, United States

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

BiotechnologyMedicalTherapeutics
Series DMar 30, 2022
Amount Raised: $41,589,867
VivaVision Biotech

Shanghai, Shanghai, China

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Biotechnology
Series DApr 21, 2021
Amount Raised: $46,217,840
Harbour Biomed

Shanghai, Shanghai, China

Harbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.

BiopharmaBiotechnologyOncologyPharmaceutical
Series CJul 9, 2020
Amount Raised: $102,800,000
Jianke

Guangzhou, Guangdong, China

Jianke is anonline B2C pharmacy and healthcare services platform.

Health CarePharmaceutical
Series BSep 4, 2018
Amount Raised: $130,000,000
Wellem

Shanghai, Shanghai, China

Wellem is an operator of pediatric clinic franchise.

Health CareHospitalWellness
Series BSep 12, 2017
Amount Raised: $30,000,000
LIGOO

Hefei, Anhui, China

LIGOO specializes in technical research, product development, and system integration of the battery management system.

AutomotiveElectric VehicleEnergyManufacturing
Series BSep 8, 2017
Amount Raised: $3,078,822
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator